These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19193504)

  • 1. Diverse molecular pathways in ovarian cancer and their clinical significance.
    Ricciardelli C; Oehler MK
    Maturitas; 2009 Mar; 62(3):270-5. PubMed ID: 19193504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Models of ovarian cancer--are we there yet?
    Garson K; Shaw TJ; Clark KV; Yao DS; Vanderhyden BC
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):15-26. PubMed ID: 15955618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular carcinogenesis of ovarian carcinoma].
    Diebold J
    Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.
    Jarboe EA; Folkins AK; Drapkin R; Ince TA; Agoston ES; Crum CP
    Histopathology; 2008 Aug; 53(2):127-38. PubMed ID: 18298580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?
    Dubeau L
    Gynecol Oncol; 1999 Mar; 72(3):437-42. PubMed ID: 10053122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distal fallopian tube: a new model for pelvic serous carcinogenesis.
    Crum CP; Drapkin R; Miron A; Ince TA; Muto M; Kindelberger DW; Lee Y
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):3-9. PubMed ID: 17218844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
    Kobayashi H; Kajiwara H; Kanayama S; Yamada Y; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
    Oncol Rep; 2009 Aug; 22(2):233-40. PubMed ID: 19578761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical molecular abnormalities in high-grade serous carcinoma of the ovary.
    Köbel M; Huntsman D; Gilks CB
    Expert Rev Mol Med; 2008 Aug; 10():e22. PubMed ID: 18671886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.
    Despierre E; Lambrechts D; Neven P; Amant F; Lambrechts S; Vergote I
    Gynecol Oncol; 2010 May; 117(2):358-65. PubMed ID: 20207398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Chlamydia-infected tubal fimbria the origin of ovarian cancer?
    Carvalho JP; Carvalho FM
    Med Hypotheses; 2008 Nov; 71(5):690-3. PubMed ID: 18703287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [P53 and its role in the ovarian surface epithelium. A review].
    Chuaire-Noack L; Sánchez-Corredor MC; Ramírez-Clavijo S
    Invest Clin; 2008 Dec; 49(4):561-93. PubMed ID: 19245174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
    Khalil I; Brewer MA; Neyarapally T; Runowicz CD
    Gynecol Oncol; 2010 Feb; 116(2):282-5. PubMed ID: 19931138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ovarian carcinogenesis: recent and past hypotheses].
    Chêne G; Penault-Llorca F; Raoelfils I; Bignon YJ; Ray-Coquard I; Seffert P; Dauplat J
    Gynecol Obstet Fertil; 2011 Apr; 39(4):216-23. PubMed ID: 21429782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.
    Geyer JT; López-García MA; Sánchez-Estevez C; Sarrió D; Moreno-Bueno G; Franceschetti I; Palacios J; Oliva E
    Am J Surg Pathol; 2009 Aug; 33(8):1157-63. PubMed ID: 19542870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenic potential of ovulatory genotoxicity.
    Murdoch WJ
    Biol Reprod; 2005 Oct; 73(4):586-90. PubMed ID: 15958727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early events in the pathogenesis of epithelial ovarian cancer.
    Landen CN; Birrer MJ; Sood AK
    J Clin Oncol; 2008 Feb; 26(6):995-1005. PubMed ID: 18195328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of early diagnosis in managing ovarian cancer.
    Dunleavey R
    Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected miscellaneous ovarian lesions: small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions.
    Clement PB
    Mod Pathol; 2005 Feb; 18 Suppl 2():S113-29. PubMed ID: 15492757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovarian cancer: morphogenesis, pathogenesis, experimental induction].
    Trofimova IN; Nikitin AIu
    Vopr Onkol; 2004; 50(4):387-98. PubMed ID: 15605760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.